Thrombotic thrombocytopenic purpura
RareBlood Disorders
Thrombotic thrombocytopenic purpura is treated with 1 medication in our database, including ACD-A. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Fresenius Kabi. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Thrombotic thrombocytopenic purpura treatment below.
What help exists for Thrombotic thrombocytopenic purpura
3
drugs indexed
1
with copay cards
1
with patient assistance
1
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Thrombotic thrombocytopenic purpura
3 totalCablivi
caplacizumab · Sanofi
🎟💙ACD-A
Anticoagulant Citrate Dextrose Solution Formula A · Fresenius Kabi
ADZYNMA
Apadamtase Alfa · Takeda
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Thrombotic thrombocytopenic purpura drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Thrombotic thrombocytopenic purpura patients
1 total · 1 openThrombotic thrombocytopenic purpura is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →